RJFSA
SRGA

Raymond James Financial Services Advisors’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-91,685
Closed -$1.25K – 3479
2023
Q3 		$1.25K Hold
91,685
– – ﹤0.01% 3257
2023
Q2 		$16.8K Buy
91,685
+80,000
+685% +$76.7K ﹤0.01% 3183
2023
Q1 		$18.7K Sell
11,685
-486
-4% -$988 ﹤0.01% 3183
2022
Q4 		$24.2K Buy
12,171
+23
+0.2% +$57 ﹤0.01% 3140
2022
Q3 		$42K Hold
12,148
– – ﹤0.01% 3104
2022
Q2 		$41K Buy
12,148
+4,573
+60% +$25.2K ﹤0.01% 3103
2022
Q1 		$69K Buy
7,575
+9
+0.1% +$137 ﹤0.01% 3157
2021
Q4 		$163K Buy
7,566
+466
+7% +$12.5K ﹤0.01% 3043
2021
Q3 		$232K Buy
7,100
+2,900
+69% +$106K ﹤0.01% 2871
2021
Q2 		$175K Hold
4,200
– – ﹤0.01% 3046
2021
Q1 		$275K Buy
4,200
+3,771
+879% +$263K ﹤0.01% 2685
2020
Q4 		$28K Hold
429
– – ﹤0.01% 2939
2020
Q3 		$23K Buy
+429
New +$32.8K ﹤0.01% 2816

Raymond James Financial Services Advisors's SRGA Position: Q4 2023 in Review

Raymond James Financial Services Advisors sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2023, closing a stake of 91,685 shares — an estimated $1.25K sold.

Raymond James Financial Services Advisors first reported a position in SRGA in Q3 2020 and held it in 13 quarters. The position peaked at $275K in Q1 2021. 0 funds tracked by Wall St. Rank hold SRGA as of Q4 2023.

  • Raymond James Financial Services Advisors reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 91,685 Surgalign Holdings, Inc. Common Stock shares in Q4 2023, an estimated $1.25K.
  • Raymond James Financial Services Advisors first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Raymond James Financial Services Advisors's Surgalign Holdings, Inc. Common Stock position peaked at $275K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.